Among these included MK1775, a WEE-1 inhibitor, and AZD7762, a CHK1/2 inhibitor (S2A Fig); dual inhibition of both cell cycle checkpoint kinases have been previously described in multiple tumor types in cell culture and in vivo [16]. This evidence concerns the gene CHEK1 and neoplasm.